0.4782
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Evofem Biosciences Inc | EVFM | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 0.4782 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.4782 | 0.4782 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.1104 - 1.57 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.4782 | USD |
Period:
Draw Mode:
Evofem Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 39.43M | 82.45M | 82.26M | $ 8.24M | $ - | -24.36 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 8.68M | $ - | - | 171.00k | 7.60% |
Evofem Biosciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EVFM Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.05 | 1.11 | 0.43 | 0.6832154 | 33,861,672 | -0.5718 | -54.46% |
| 1 Month | 1.04 | 1.11 | 0.43 | 0.8170574 | 23,489,320 | -0.5618 | -54.02% |
| 3 Months | 0.495 | 1.57 | 0.275 | 0.985983 | 39,784,950 | -0.0168 | -3.39% |
| 6 Months | 0.4191 | 1.57 | 0.1104 | 0.9310586 | 19,754,427 | 0.0591 | 14.1% |
| 1 Year | 0.8209 | 1.57 | 0.1104 | 0.8730101 | 11,574,776 | -0.3427 | -41.75% |
| 3 Years | 5.05 | 8.99 | 0.1104 | 1.33 | 6,150,677 | -4.57 | -90.53% |
| 5 Years | 11.81 | 12.56 | 0.1104 | 1.35 | 4,099,641 | -11.33 | -95.95% |
Evofem Biosciences Description
| Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The company's product, Phexxi (lactic acid, citric acid and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The company is also evaluating its investigational drug candidate EVO100 vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women. |